Teva knocked as competition fears grow for MS drug | Financial Times
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceutical Industries Ltd. – Artonpapers
Teva Settles Price-Fixing-Related Securities Class Action Litigation for $420 Million | The D&O Diary
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Completes Plan B One-Step Asset Sale To Foundation Consumer Healthcare For $675M